Advertisement
More than one in four doctors-in-training may be depressed

Depression Not Uncommon Among Resident Physicians

0
Grueling medical training may help explain finding
Despite an increase in the number of U.S. medical school graduates

Percentage of Graduates Entering GME Stable Over Past Decade

0
Despite increase in number of U.S. medical school graduates, no change in GME placement
Dozens of gynecologists

Doctors Rally in Support of Morcellator Use Curbed by FDA

0
Agency overstated odds of power morcellator spreading cancer, review group says

American Society of Hematology, Dec. 5-8

0
The 57th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
Capecitabine appears to reduce risk of recurrence for breast cancer patients with residual disease after presurgery chemotherapy

SABCS: Adding Capecitabine Ups Outcomes for Breast CA Patients

0
Linked to longer disease-free survival; second study links denosumab to reduced risk of recurrence
β-blockers and angiotensin-converting enzyme inhibitors can prevent heart damage in breast cancer patients as they undergo chemotherapy

SABCS: β-Blockers, ACEIs May Protect Heart During Chemo

0
May also lower risk of complications that can interrupt breast cancer treatment
The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

0
Designed for women diagnosed with breast cancer
The expansion of insurance coverage and increases in retail prescription drug spending contributed to an increase in total national health care expenditures in 2014

U.S. Health Care Spending Increased in 2014

0
Increase in 2014 followed five consecutive years of historically low health care spending
Oral venetoclax and acalabrutinib are active in patients with relapsed or refractory chronic lymphocytic leukemia

ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL

0
Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
The rate of vaso-occlusive crisis events is not significantly lower for children and adolescents with sickle-cell anemia receiving prasugrel versus placebo

ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell

0
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo